Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Fischer

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Medicinal Chemistry|June 1, 1991
Binding of substituted and conformationally restricted derivatives of N-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane at sigma-receptorsR A Glennon, A M Ismaiel, J D Smith, et al.
Annals of the New York Academy of Sciences|September 15, 1995
Neuroprotective use-dependent blockers of Na+ and Ca2+ channels controlling presynaptic release of glutamateS M Goldin, K Subbarao, R Sharma, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989
Synthesis and characterization of a series of diarylguanidines that are noncompetitive N-methyl-D-aspartate receptor antagonists with neuroprotective propertiesJ F Keana, R N McBurney, M W Scherz, et al.
Journal of Medicinal Chemistry|January 21, 1994
Synthesis and structure-activity studies of N,N'-diarylguanidine derivatives. N-(1-naphthyl)-N'-(3-ethylphenyl)-N'-methylguanidine: a new, selective noncompetitive NMDA receptor antagonistN L Reddy, L Y Hu, R E Cotter, et al.
Journal of Medicinal Chemistry|August 14, 1998
Synthesis and pharmacological evaluation of N,N'-diarylguanidines as potent sodium channel blockers and anticonvulsant agentsN L Reddy, W Fan, S S Magar, et al.
Journal of Medicinal Chemistry|September 1, 1990
Synthesis and structure-activity relationships of N,N'-di-o-tolylguanidine analogues, high-affinity ligands for the haloperidol-sensitive sigma receptorM W Scherz, M Fialeix, J B Fischer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
Cloning of the cDNA and gene for a human D2 dopamine receptorD K Grandy, M A Marchionni, H Makam, et al.
Journal of Medicinal Chemistry|July 31, 1998
Design, synthesis, and pharmacological evaluation of conformationally constrained analogues of N,N'-diaryl- and N-aryl-N-aralkylguanidines as potent inhibitors of neuronal Na+ channelsM C Maillard, M E Perlman, O Amitay, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Solution-phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockersS Padmanabhan, R C Lavin, P M Thakker, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Medicinal Chemistry|June 1, 1991
Binding of substituted and conformationally restricted derivatives of N-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane at sigma-receptorsR A Glennon, A M Ismaiel, J D Smith, et al.
Annals of the New York Academy of Sciences|September 15, 1995
Neuroprotective use-dependent blockers of Na+ and Ca2+ channels controlling presynaptic release of glutamateS M Goldin, K Subbarao, R Sharma, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989
Synthesis and characterization of a series of diarylguanidines that are noncompetitive N-methyl-D-aspartate receptor antagonists with neuroprotective propertiesJ F Keana, R N McBurney, M W Scherz, et al.
Journal of Medicinal Chemistry|January 21, 1994
Synthesis and structure-activity studies of N,N'-diarylguanidine derivatives. N-(1-naphthyl)-N'-(3-ethylphenyl)-N'-methylguanidine: a new, selective noncompetitive NMDA receptor antagonistN L Reddy, L Y Hu, R E Cotter, et al.
Journal of Medicinal Chemistry|August 14, 1998
Synthesis and pharmacological evaluation of N,N'-diarylguanidines as potent sodium channel blockers and anticonvulsant agentsN L Reddy, W Fan, S S Magar, et al.
Journal of Medicinal Chemistry|September 1, 1990
Synthesis and structure-activity relationships of N,N'-di-o-tolylguanidine analogues, high-affinity ligands for the haloperidol-sensitive sigma receptorM W Scherz, M Fialeix, J B Fischer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
Cloning of the cDNA and gene for a human D2 dopamine receptorD K Grandy, M A Marchionni, H Makam, et al.
Journal of Medicinal Chemistry|July 31, 1998
Design, synthesis, and pharmacological evaluation of conformationally constrained analogues of N,N'-diaryl- and N-aryl-N-aralkylguanidines as potent inhibitors of neuronal Na+ channelsM C Maillard, M E Perlman, O Amitay, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Solution-phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockersS Padmanabhan, R C Lavin, P M Thakker, et al.
Pageof 4